Partnership or buyout it is all about the clinical and preclinical data, page-3

Wombat, many thanks for pulling all this information together and sharing it here on HC. You're an absolute legend.

Was hoping to clarify something.
Phil states in the video that the campaign to market to big pharma will begin later this year, 2021. Your conclusion is that RAC will start shopping the data to Big Pharma at the end of 2022 and they won't start "shopping" bisantrene/zantrene until they have this data. The statement from Phil seems to contradict your expectations. How do you reconcile these two seemly conflicting timelines?

Phil.... "But that campaign if I may call it that to market our company should be concentrated should be focused and should be deliberate and so when we started it will be exactly that a little bit like selling your house you don't want to sell your house over 12 months you need to do it on a concentrated basis and we'll do so later in the year."